239 related articles for article (PubMed ID: 15026545)
1. A new class of peroxisome proliferator-activated receptor gamma (PPARgamma) agonists that inhibit growth of breast cancer cells: 1,1-Bis(3'-indolyl)-1-(p-substituted phenyl)methanes.
Qin C; Morrow D; Stewart J; Spencer K; Porter W; Smith R; Phillips T; Abdelrahim M; Samudio I; Safe S
Mol Cancer Ther; 2004 Mar; 3(3):247-60. PubMed ID: 15026545
[TBL] [Abstract][Full Text] [Related]
2. 1,1-Bis(3'-indolyl)-1-(p-substitutedphenyl)methanes induce peroxisome proliferator-activated receptor gamma-mediated growth inhibition, transactivation, and differentiation markers in colon cancer cells.
Chintharlapalli S; Smith R; Samudio I; Zhang W; Safe S
Cancer Res; 2004 Sep; 64(17):5994-6001. PubMed ID: 15342379
[TBL] [Abstract][Full Text] [Related]
3. Peroxisome proliferator-activated receptor gamma agonists induce proteasome-dependent degradation of cyclin D1 and estrogen receptor alpha in MCF-7 breast cancer cells.
Qin C; Burghardt R; Smith R; Wormke M; Stewart J; Safe S
Cancer Res; 2003 Mar; 63(5):958-64. PubMed ID: 12615709
[TBL] [Abstract][Full Text] [Related]
4. 1,1-Bis(3'-indolyl)-1-(p-substituted phenyl)methanes inhibit proliferation of estrogen receptor-negative breast cancer cells by activation of multiple pathways.
Vanderlaag K; Su Y; Frankel AE; Grage H; Smith R; Khan S; Safe S
Breast Cancer Res Treat; 2008 May; 109(2):273-83. PubMed ID: 17624585
[TBL] [Abstract][Full Text] [Related]
5. Inhibition of tumor-necrosis-factor-alpha induced endothelial cell activation by a new class of PPAR-gamma agonists. An in vitro study showing receptor-independent effects.
Calabrò P; Samudio I; Safe SH; Willerson JT; Yeh ET
J Vasc Res; 2005; 42(6):509-16. PubMed ID: 16155367
[TBL] [Abstract][Full Text] [Related]
6. Peroxisome proliferator-activated receptor gamma-dependent activity of indole ring-substituted 1,1-bis(3'-indolyl)-1-(p-biphenyl)methanes in cancer cells.
Guo J; Chintharlapalli S; Lee SO; Cho SD; Lei P; Papineni S; Safe S
Cancer Chemother Pharmacol; 2010 May; 66(1):141-50. PubMed ID: 19823826
[TBL] [Abstract][Full Text] [Related]
7. Expression of NAG-1, a transforming growth factor-beta superfamily member, by troglitazone requires the early growth response gene EGR-1.
Baek SJ; Kim JS; Nixon JB; DiAugustine RP; Eling TE
J Biol Chem; 2004 Feb; 279(8):6883-92. PubMed ID: 14662774
[TBL] [Abstract][Full Text] [Related]
8. Peroxisome proliferator-activated receptor-gamma activator 15-deoxy-Delta12,14-prostaglandin J2 inhibits neuroblastoma cell growth through induction of apoptosis: association with extracellular signal-regulated kinase signal pathway.
Kim EJ; Park KS; Chung SY; Sheen YY; Moon DC; Song YS; Kim KS; Song S; Yun YP; Lee MK; Oh KW; Yoon DY; Hong JT
J Pharmacol Exp Ther; 2003 Nov; 307(2):505-17. PubMed ID: 12966153
[TBL] [Abstract][Full Text] [Related]
9. 1,1-Bis(3'-indolyl)-1-(p-substituted phenyl)methanes inhibit colon cancer cell and tumor growth through PPARgamma-dependent and PPARgamma-independent pathways.
Chintharlapalli S; Papineni S; Safe S
Mol Cancer Ther; 2006 May; 5(5):1362-70. PubMed ID: 16731770
[TBL] [Abstract][Full Text] [Related]
10. Peroxisome proliferator-activated receptor gamma ligand inhibits cell growth and invasion of human pancreatic cancer cells.
Hashimoto K; Ethridge RT; Evers BM
Int J Gastrointest Cancer; 2002; 32(1):7-22. PubMed ID: 12630765
[TBL] [Abstract][Full Text] [Related]
11. A non-thiazolidinedione partial peroxisome proliferator-activated receptor gamma ligand inhibits vascular smooth muscle cell growth.
Bruemmer D; Berger JP; Liu J; Kintscher U; Wakino S; Fleck E; Moller DE; Law RE
Eur J Pharmacol; 2003 Apr; 466(3):225-34. PubMed ID: 12694805
[TBL] [Abstract][Full Text] [Related]
12. 1,1-Bis(3'-indolyl)-1-(p-substituted phenyl)methanes inhibit ovarian cancer cell growth through peroxisome proliferator-activated receptor-dependent and independent pathways.
Lei P; Abdelrahim M; Safe S
Mol Cancer Ther; 2006 Sep; 5(9):2324-36. PubMed ID: 16985067
[TBL] [Abstract][Full Text] [Related]
13. Peroxisome proliferator-activated receptor gamma ligands differentially modulate muscle cell differentiation and MyoD gene expression via peroxisome proliferator-activated receptor gamma -dependent and -independent pathways.
Hunter JG; van Delft MF; Rachubinski RA; Capone JP
J Biol Chem; 2001 Oct; 276(41):38297-306. PubMed ID: 11477074
[TBL] [Abstract][Full Text] [Related]
14. Peroxisome proliferator-activated receptor gamma1 (PPARgamma1) expresses in rat mesangial cells and PPARgamma agonists modulate its differentiation.
Asano T; Wakisaka M; Yoshinari M; Iino K; Sonoki K; Iwase M; Fujishima M
Biochim Biophys Acta; 2000 Jun; 1497(1):148-54. PubMed ID: 10838168
[TBL] [Abstract][Full Text] [Related]
15. Peroxisome proliferator-activated receptor gamma ligands, 15-deoxy-Delta12,14-prostaglandin J2, and ciglitazone, induce growth inhibition and cell cycle arrest in hepatic oval cells.
Cheng J; Nakamura H; Imanishi H; Liu W; Morisaki T; Sugiyama T; Hada T
Biochem Biophys Res Commun; 2004 Sep; 322(2):458-64. PubMed ID: 15325252
[TBL] [Abstract][Full Text] [Related]
16. PPARgamma agonists inhibit cell growth and suppress the expression of cyclin D1 and EGF-like growth factors in ras-transformed rat intestinal epithelial cells.
Kitamura S; Miyazaki Y; Hiraoka S; Nagasawa Y; Toyota M; Takakura R; Kiyohara T; Shinomura Y; Matsuzawa Y
Int J Cancer; 2001 Nov; 94(3):335-42. PubMed ID: 11745411
[TBL] [Abstract][Full Text] [Related]
17. 1,1-bis(3'-indolyl)-1-(p-substitutedphenyl)methanes induce apoptosis and inhibit renal cell carcinoma growth.
York M; Abdelrahim M; Chintharlapalli S; Lucero SD; Safe S
Clin Cancer Res; 2007 Nov; 13(22 Pt 1):6743-52. PubMed ID: 18006776
[TBL] [Abstract][Full Text] [Related]
18. PPAR gamma ligands, 15-deoxy-delta12,14-prostaglandin J2 and rosiglitazone regulate human cultured airway smooth muscle proliferation through different mechanisms.
Ward JE; Gould H; Harris T; Bonacci JV; Stewart AG
Br J Pharmacol; 2004 Feb; 141(3):517-25. PubMed ID: 14718259
[TBL] [Abstract][Full Text] [Related]
19. Inhibition of bladder tumor growth by 1,1-bis(3'-indolyl)-1-(p-substitutedphenyl)methanes: a new class of peroxisome proliferator-activated receptor gamma agonists.
Kassouf W; Chintharlapalli S; Abdelrahim M; Nelkin G; Safe S; Kamat AM
Cancer Res; 2006 Jan; 66(1):412-8. PubMed ID: 16397256
[TBL] [Abstract][Full Text] [Related]
20. Peroxisome proliferator--activated receptor gamma activators inhibit interleukin-1beta-induced nitric oxide and matrix metalloproteinase 13 production in human chondrocytes.
Fahmi H; Di Battista JA; Pelletier JP; Mineau F; Ranger P; Martel-Pelletier J
Arthritis Rheum; 2001 Mar; 44(3):595-607. PubMed ID: 11263774
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
